Revenue for Q4 FY19 of INR 2,579 Million, a growth of 16% (y-o-y) and for FY19 of INR 9,787 Million,…
Mumbai, March 08, 2018: Sun Pharmaceutical’s troubles with the US drug regulator will continue, as details of the recent observations…